Therapeutic targeting of transcriptional cyclin-dependent kinases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic targeting of transcriptional cyclin-dependent kinases

Published:2018-11-09 Issue:2 Volume:10 Page:118-136
ISSN:2154-1264
Container-title:Transcription
language:en
Short-container-title:Transcription

Author:

Galbraith Matthew D.¹²^ORCID,Bender Heather¹²^ORCID,Espinosa Joaquín M.¹²³^ORCID

Affiliation:

1. Linda Crnic Institute for Down Syndrome, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

2. Department of Pharmacology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

3. Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, CO, USA

Funder

NIH/NIGMS

NSF

NIH/NCI

Publisher

Informa UK Limited

Subject

Genetics,Biochemistry,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21541264.2018.1539615

Reference147 articles.

1. The Protein Kinase Complement of the Human Genome

2. Cyclin-dependent kinases

3. The CDK Network: Linking Cycles of Cell Division and Gene Expression

4. Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs

5. Born to run: control of transcription elongation by RNA polymerase II

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and preclinical profile of YK-2168, a differentiated selective CDK9 inhibitor in clinical development;Bioorganic & Medicinal Chemistry Letters;2024-11

2. Recent Development of CDK2 Inhibitors as Anticancer Drugs: An Update (2015–2023);Pharmaceutical Fronts;2024-09-03

3. Transcriptional regulation and therapeutic potential of cyclin-dependent kinase 9 (CDK9) in sarcoma;Biochemical Pharmacology;2024-08

4. Exploring isoindolin-1-ones as potential CDK7 inhibitors using cheminformatic tools;In Silico Pharmacology;2024-06-04

5. Rapid P-TEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy;Nature Communications;2024-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3